IMS 2023 | Addressing financial toxicity and time toxicity among patients with multiple myeloma
Rahul Banerjee, MD, Fred Hutchinson Cancer Center, Seattle, WA, discusses a study which evaluated financial toxicity and time toxicity in patients with multiple myeloma. Dr Banerjee highlights that financial toxicity was found to be fairly stable among patients, and interestingly, time toxicity was reported in patients on active therapy as well as patients on maintenance therapy. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consulting/advisory: SparkCures, Sanofi Pasteur, Genentech/Roche, Janssen Oncology, Bristol-Myers Squibb/Celgene, Caribou Biosciences, Pfizer
Research funding: Pack Health
